CRON - Cronos Group Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
8.32
-0.54 (-6.09%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close8.86
Open9.14
Bid8.32 x 3200
Ask8.34 x 3000
Day's Range8.27 - 9.14
52 Week Range6.50 - 25.10
Volume12,864,546
Avg. Volume4,779,964
Market Cap2.781B
Beta (3Y Monthly)3.26
PE Ratio (TTM)N/A
EPS (TTM)-0.03
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Hexo to sell ‘Original Stash’ at black market prices
    Yahoo Finance Video

    Hexo to sell ‘Original Stash’ at black market prices

    Canadian cannabis company Hexo is launching an “Original Stash” cannabis line with prices that compete directly with the black market in an effort to hurt the black market. Yahoo Finance's Dan Roberts, Heidi Chung and Kristin Myers discuss on YFi AM.

  • Cannabis stocks a sea of red as Green Organic’s financing woes weigh
    MarketWatch

    Cannabis stocks a sea of red as Green Organic’s financing woes weigh

    Cannabis stocks were a sea of red on Friday, weighed down by Green Organic Dutchman’s 14% decline after it said it would cut costs and adopt a plan to reduce its financing needs as it grapples with a smaller-than-expected Canadian market

  • Why An Analyst Calls This Cannabis Stock The 'New King In The North'
    Investor's Business Daily

    Why An Analyst Calls This Cannabis Stock The 'New King In The North'

    Canadian cannabis producer Cronos Group is "a new king in the north," an analyst said in upgrading the stock.

  • E-Cigarette Ban in New York: Impact on Cannabis Sector
    Market Realist

    E-Cigarette Ban in New York: Impact on Cannabis Sector

    The vaping crisis has brought on some twists and turns for the cannabis sector. New York courts are now weighing an e-cigarette ban.

  • Pot stocks ‘significantly oversold’: ETF manager
    Yahoo Finance

    Pot stocks ‘significantly oversold’: ETF manager

    Legal pot could provide "significant upside" for investors, ETF manager says

  • Market Realist

    Why Did HEXO Rise 17% on Thursday?

    Hexo (HEXO) had a hard time last week. A lot of headwinds pulled the stock down. However, the stock rose and closed with a gain of 17% on Thursday.

  • Aurora Cannabis Plans to Launch Vapes despite Concerns
    Market Realist

    Aurora Cannabis Plans to Launch Vapes despite Concerns

    Despite vaping concerns, Aurora Cannabis plans to introduce vape products in December. Reports of vaping-related illnesses started in late August.

  • TheStreet.com

    Cronos Shares, 'King' of Canada Cannabis, Upgraded to Buy at Stifel

    At the same time Stifel's Andrew Carter lowered his price target on the stock to C$14 (US$10.66) from C$16.50. Carter sees Cronos's C$2 billion of cash on hand making it "unconstrained" in its ability to invest toward a global cannabis market opportunity of $200 billion.

  • Marijuana Stocks Enter Legalization 2.0, Unveil These New Products
    Investor's Business Daily

    Marijuana Stocks Enter Legalization 2.0, Unveil These New Products

    Marijuana stocks mostly rebounded Thursday, a day that marks the start of the next phase of recreational cannabis sales in Canada.

  • Benzinga

    PreMarket Prep Recap: Netflix's Early Gains, And What Is Going On With Cronos?

    For some unexplained reason, there was a relentless buyer in the issue on huge volume. To begin the regular session, the issue opened at the high for the day, $10.56, and has traded as low as $8.33. After the close Wednesday, Netflix Inc (NASDAQ: NFLX) delivered a solid third-quarter beat for EPS and sales.

  • Benzinga

    Cronos Group's 40% After-Hours Mystery Rally: What We Know

    Cronos Group Inc. (NASDAQ: CRON) shares spiked 41.5% during Wednesday's after-market session at about 6:20 p.m. Peers such as Aurora Cannabis Inc (NYSE: ACB) and Tilray Inc (NASDAQ: TLRY) made significant moves higher in sympathy with Cronos Group. Many pot stocks had a rough time during Wednesday's regular session.

  • Why Cronos Rose 33% in After-Hours Trading on Wednesday
    Market Realist

    Why Cronos Rose 33% in After-Hours Trading on Wednesday

    Cronos Group (CRON) stock rose 33% with a heavy volume in after-hours trading on Wednesday. Marijuana stocks are on a rollercoaster ride.

  • Cresco Labs Stock Rises on Dispensary Approval
    Market Realist

    Cresco Labs Stock Rises on Dispensary Approval

    Yesterday, Cresco Labs (CRLBF) (CL) announced it had received licenses for its five Illinois medical cannabis dispensaries to sell adult-use cannabis.

  • Aurora Cannabis: Preview of Its Cannabis 2.0 Strategy
    Market Realist

    Aurora Cannabis: Preview of Its Cannabis 2.0 Strategy

    On Wednesday, Aurora Cannabis gave a preview of its Cannabis 2.0 strategy. The company provided plans for the roll-out of edibles, concentrates, and vapes.

  • Dow Jones Futures Rally On Brexit Deal; Netflix Earnings Crush Views, Pot Stock Cronos Soars; IBM Dives
    Investor's Business Daily

    Dow Jones Futures Rally On Brexit Deal; Netflix Earnings Crush Views, Pot Stock Cronos Soars; IBM Dives

    Dow Jones futures rose on a tentative Brexit deal. Netflix soared as earnings crushed views despite a subscriber miss. Marijuana stocks rose, led by Cronos Group. IBM dived.

  • MarketWatch

    UPDATE: Cronos shares surge roughly 33% in after hours

    Shares of Cronos Group Inc. rampaged in the extended session Wednesday, gaining as much as 41.5% as of 6:22 p.m. Eastern time on heavy volume, before dropping to a 33% gain at 6:45 p.m. Eastern time. It was not immediately clear why the stock surged in the extended session but two block trades totaling roughly 1.2 million shares crossed at 5:09 p.m. Eastern time at a price of $8.40 a share. If Cronos shares hold on to the gains, the late Wednesday move will be the second largest in the company's history and the largest since the company began trading on the Nasdaq. Previously other cannabis companies' stocks, such as CannTrust Holdings Inc. have notched double-digit gains because an exchange traded fund has re-balanced its portfolio after significant changes to the market price. Cronos Group stock closed up roughly 1% to $8.40 during the regular session. The stock was up 14% in premarket trade Thursday.

  • Aphria: Analysts’ Target Price and Ratings after Earnings
    Market Realist

    Aphria: Analysts’ Target Price and Ratings after Earnings

    Aphria (APHA) reported impressive results for the first quarter of fiscal 2020 on Tuesday. The stock has gained 9.6% since its earnings.

  • Market Exclusive

    Market Morning: Chinese Aircraft Carriers, DUP Sours on Brexit Deal, Big Opioid Settlement

    Chinese Aircraft Carrier Factory Revealed This will probably annoy the Trump Administration. Reuters reports exclusively that high-resolution satellite images show that China is progressing in the construction of a full sized aircraft carrier and should be the first of several large vessels produced. The site is called the Jinagnan shipyard and the images were taken […]The post Market Morning: Chinese Aircraft Carriers, DUP Sours on Brexit Deal, Big Opioid Settlement appeared first on Market Exclusive.

  • Cannabis Roundup: HEXO, APHA, CRLBF, and CRON
    Market Realist

    Cannabis Roundup: HEXO, APHA, CRLBF, and CRON

    Hexo launched Original Stash, a value cannabis brand. Hexo's CEO stated that the company intends to educate consumers and "disrupt the illicit market."

  • Benzinga

    Najarian Brothers Highlight Unusual Activity In Signet Jewelers, Cronos And More

    On CNBC's "Fast Money Halftime Report," Pete Najarian said options traders are buying the April $22 calls in Signet Jewelers Ltd. (NYSE: SIG). Pete Najarian followed the trade and he is going to hold the position probably until April. Pete Najarian loves the risk-reward for the trade and he thinks somebody is positioning for the move to the upside.

  • Marijuana Stocks Make These Moves In A New Cannabis Market
    Investor's Business Daily

    Marijuana Stocks Make These Moves In A New Cannabis Market

    An Australian JV set up by Cronos is launching an IPO, while Canopy Growth is shedding its stake in a company there.

  • 10 Canadian Marijuana Stocks for Your Portfolio
    Investopedia

    10 Canadian Marijuana Stocks for Your Portfolio

    With marijuana legalized in Canada, these penny stocks offer direct exposure and could help you get a piece of the pot.

  • Marijuana stocks, after declines of over 50%, are now only ludicrously overpriced
    MarketWatch

    Marijuana stocks, after declines of over 50%, are now only ludicrously overpriced

    The pot bubble has burst, but many companies’ shares are still trading at unjustified levels, says Brian Livingston.

  • MarketWatch

    Canadian cannabis company Cronos says Australian joint venture is planning a November IPO

    Canadian cannabis company Cronos Group Inc. said Wednesday its 50/50 joint venture with NewSouthern Capital Pty Ltd. called Cronos Australia is planning to offer 40 million shares in an initial public offering planned for November. The company is expected to price the deal at AUD$0.50 ($0.34) a share. The venture was formed in February of 2018. Once the deal has been completed, Cronos will own a 31% stake in Cronos Australia, which is expected to have an initial market capitalization of AUD$64.4 million. Cronos shares were up 1.6% in premarket trade, but have fallen 20% in 2019, while the ETFMG Alternative Harvest ETF has fallen 21% and the S&P 500 has gained about 20%.

  • GlobeNewswire

    Cronos Group Issues Statement on Separately Announced IPO of Cronos Australia

    Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today noted the separately announced AUD$20 million initial public offering of Cronos Australia Limited (“Cronos Australia”). Under the offering, Cronos Australia is expected to issue 40 million new shares at an offering price of AUD$0.50 per share (the “Cronos Australia IPO”) ahead of its planned listing on the Australian Securities Exchange in November 2019. Established in February 2018, Cronos Australia is a 50/50 joint venture between Cronos Group and NewSouthern Capital Pty Ltd., and is led by Rodney Cocks and Peter Righetti.  The launch marked a significant milestone in Cronos Group’s commitment to advancing cannabis research and producing and distributing products and brands at a global scale.